Ayana T Moore
Overview
Explore the profile of Ayana T Moore including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
315
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rogers B, Mendez N, Mimiaga M, Sherman S, Closson E, Tangmunkongvorakul A, et al.
Int J Behav Med
. 2018 Aug;
26(1):17-27.
PMID: 30105603
Purpose: There have been significant biomedical improvements in the treatment and prevention of HIV over the past few decades. However, new transmissions continue to occur. Alcohol use is a known...
2.
Safren S, Hughes J, Mimiaga M, Moore A, Friedman R, Srithanaviboonchai K, et al.
J Int AIDS Soc
. 2016 Oct;
19(1):21096.
PMID: 27687145
Introduction: Successful global treatment as prevention (TasP) requires identifying HIV-positive individuals at high risk for transmitting HIV, and having impact via potential infections averted. This study estimated the frequency and...
3.
Magidson J, Li X, Mimiaga M, Moore A, Srithanaviboonchai K, Friedman R, et al.
AIDS Behav
. 2015 Aug;
20(4):699-709.
PMID: 26246068
Successful biomedical prevention/treatment-as-prevention (TasP) requires identifying individuals at greatest risk for transmitting HIV, including those with antiretroviral therapy (ART) nonadherence and/or 'amplified HIV transmission risk,' defined as condomless sex with...
4.
Closson E, Mimiaga M, Sherman S, Tangmunkongvorakul A, Friedman R, Limbada M, et al.
PLoS One
. 2015 Mar;
10(3):e0120957.
PMID: 25793283
The success of global treatment as prevention (TasP) efforts for individuals living with HIV/AIDS (PLWHA) is dependent on successful implementation, and therefore the appropriate contribution of social and behavioral science...
5.
Peris L, Wagenbach M, Lafanechere L, Brocard J, Moore A, Kozielski F, et al.
J Cell Biol
. 2009 Jul;
185(7):1159-66.
PMID: 19564401
In cells, stable microtubules (MTs) are covalently modified by a carboxypeptidase, which removes the C-terminal Tyr residue of alpha-tubulin. The significance of this selective detyrosination of MTs is not understood....
6.
Stumpff J, Cooper J, Domnitz S, Moore A, Rankin K, Wagenbach M, et al.
Methods Mol Biol
. 2007 Oct;
392:37-49.
PMID: 17951709
Cellular microtubules are rigid in comparison to other cytoskeletal elements (1,2). To facilitate cytoplasmic remodeling and timely responses to cell signaling events, microtubules depolymerize and repolymerize rapidly at their ends...
7.
Moore A, Rankin K, von Dassow G, Peris L, Wagenbach M, Ovechkina Y, et al.
J Cell Biol
. 2005 May;
169(3):391-7.
PMID: 15883193
MCAK is a member of the kinesin-13 family of microtubule (MT)-depolymerizing kinesins. We show that the potent MT depolymerizer MCAK tracks (treadmills) with the tips of polymerizing MTs in living...